These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 33887455)
1. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature. Birlutiu V; Feiereisz AI; Oprinca G; Dobritoiu S; Rotaru M; Birlutiu RM; Iancu GM Int J Infect Dis; 2021 Jun; 107():72-77. PubMed ID: 33887455 [TBL] [Abstract][Full Text] [Related]
2. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection. Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645 [TBL] [Abstract][Full Text] [Related]
3. Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review. Arabzadeh Bahri R; Esmaeilpur Abianeh F; Peisepar M; Hadi R; Basti FA; Maleki S; Radkhah H Ear Nose Throat J; 2024 Jun; 103(1_suppl):164S-170S. PubMed ID: 38411125 [No Abstract] [Full Text] [Related]
4. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection. Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524 [TBL] [Abstract][Full Text] [Related]
5. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study. Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035 [TBL] [Abstract][Full Text] [Related]
7. Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients. Algahtani SN; Alzarroug AF; Alghamdi HK; Algahtani HK; Alsywina NB; Bin Abdulrahman KA Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162068 [TBL] [Abstract][Full Text] [Related]
8. Negative correlation between ACE2 gene expression levels and loss of taste in a cohort of COVID-19 hospitalized patients: New clues to long-term cognitive disorders. Braga-Paz I; Ferreira de Araújo JL; Alves HJ; de Ávila RE; Resende GG; Teixeira MM; de Aguiar RS; de Souza RP; Bahia D Front Cell Infect Microbiol; 2022; 12():905757. PubMed ID: 36250059 [TBL] [Abstract][Full Text] [Related]
9. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948 [TBL] [Abstract][Full Text] [Related]
10. Clinical presentations, systemic inflammation response and ANDC scores in hospitalized patients with COVID-19. Hsu JL; Liu MC; Tsau PW; Chung FT; Lin SM; Chen ML; Ro LS Sci Rep; 2024 Sep; 14(1):22480. PubMed ID: 39341876 [TBL] [Abstract][Full Text] [Related]
11. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study. Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899 [TBL] [Abstract][Full Text] [Related]
12. Neurological and Head/Eyes/Ears/Nose/Throat Manifestations of COVID-19: A Systematic Review and Meta-Analysis. Ganesh A; Reis IR; Varma M; Patry DG; Cooke LJ Can J Neurol Sci; 2022 Jul; 49(4):514-531. PubMed ID: 34287109 [TBL] [Abstract][Full Text] [Related]
13. Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues. Ricardo Criado P; Pincelli TPH; Criado RFJ; Abdalla BMZ; Belda Junior W Exp Dermatol; 2020 Oct; 29(10):936-944. PubMed ID: 32867008 [TBL] [Abstract][Full Text] [Related]
14. Erythema annulare centrifugum with anosmia and ageusia in a SARS-CoV-2 exposed patient successfully treated with doxycycline. Montinari M; Atzori L; Valdevit S; Rongioletti F Int J Dermatol; 2021 Mar; 60(3):384-386. PubMed ID: 33368328 [No Abstract] [Full Text] [Related]
15. Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients. Finsterer J; Stollberger C J Med Virol; 2020 Oct; 92(10):1793-1794. PubMed ID: 32311107 [No Abstract] [Full Text] [Related]
16. Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations. Garduño-Soto M; Choreño-Parra JA; Cazarin-Barrientos J Arch Dermatol Res; 2021 Oct; 313(8):611-622. PubMed ID: 33159236 [TBL] [Abstract][Full Text] [Related]
17. Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19? Sen A Med Hypotheses; 2021 Aug; 153():110627. PubMed ID: 34139598 [TBL] [Abstract][Full Text] [Related]
18. The aftermath of COVID-19: between anosmia and ageusia. Medina Gamero A; Regalado Chamorro M; Guillen Rojas N Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(3):200. PubMed ID: 35577438 [No Abstract] [Full Text] [Related]
20. Case Report: COVID-19 Patient With Chief Complaint of Anosmia and Ageusia; a Unique Perspective on Atypical Symptomatology and Management in the Military. Smith LTAC; Hodges CDRJ; Pratt M; Porter IM Mil Med; 2020 Dec; 185(11-12):e2176-e2179. PubMed ID: 32776115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]